News >

Myeloma Regimens Require Coping Mechanisms for Toxicity

Ellie Leick
Published: Monday, Oct 14, 2019

Adam J. Waxman, MD, MS, assistant professor of clinical medicine at the University of Pennsylvania

Adam J. Waxman, MD, MS

Multiple myeloma treatment has made significant strides, but many of the regimens cause considerable toxicity, making it a priority to optimally manage the associated adverse events (AEs) or create less-toxic approaches, explained Adam J. Waxman, MD, MS.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication